We are live on ! Find out more
LAB icon

Standard BioTools
LAB

109 hedge funds and large institutions have $252M invested in Standard BioTools in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $7.69M

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 107 → 109 (+2)

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

66% less capital invested

Capital invested by funds: $750M → $252M (-$498M)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
3.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
36
Reduced
35
Closed
22
Calls
$12.8M
Puts
$7.69M
Net Calls
+$5.15M
Net Calls Change
+$4.4M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$20.6M
2
Capital World Investors
Capital World Investors
California
+$12.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.97M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.87M
5
Goldman Sachs
Goldman Sachs
New York
+$7.33M

Top Sellers

1
Jennison Associates
Jennison Associates
New York
-$27.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.7M
3
JP Morgan Chase
JP Morgan Chase
New York
-$14.8M
4
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM)
Texas
-$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$129K – – –
OPPM
77
Opus Point Partners Management
New York
$122K +$236K +15,000 New
Wells Fargo
78
Wells Fargo
California
$118K -$114K -7,239 -33%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$115K +$144K +9,144 +180%
Jane Street
80
Jane Street
New York
$93K +$180K +11,453 New
UBS AM
81
UBS AM
Illinois
$82K – – –
WMSA
82
Weiss Multi-Strategy Advisers
New York
$81K -$157K -10,000 -50%
Morgan Stanley
83
Morgan Stanley
New York
$80K +$99K +6,290 +177%
BG
84
BlackRock Group
United Kingdom
$67K +$20.7K +1,316 +19%
HCM
85
Highlander Capital Management
New Jersey
$64K -$7.87K -500 -6%
UBS Group
86
UBS Group
Switzerland
$57K +$61.1K +3,883 +120%
BNP Paribas Financial Markets
87
BNP Paribas Financial Markets
France
$47.7K +$54.6K +3,466 +144%
Creative Planning
88
Creative Planning
Kansas
$41K +$78.7K +5,000 New
Simplex Trading
89
Simplex Trading
Illinois
$38K +$59.4K +3,772 +365%
Legal & General Group
90
Legal & General Group
United Kingdom
$36K – – –
Teacher Retirement System of Texas
91
Teacher Retirement System of Texas
Texas
$28K +$37.9K +2,410 +219%
Group One Trading
92
Group One Trading
Illinois
$21K +$39K +2,479 +4,767%
QT
93
Quantbot Technologies
New York
$17K +$33.1K +2,105 New
Canada Life
94
Canada Life
Manitoba, Canada
$15K – – –
PAM
95
Panagora Asset Management
Massachusetts
$14K -$58.9K -3,740 -69%
CSS
96
Cubist Systematic Strategies
Connecticut
$13K -$81.8K -5,197 -76%
TRCT
97
Tower Research Capital (TRC)
New York
$10K +$18.2K +1,154 +1,390%
BlackRock
98
BlackRock
New York
$5K – – –
SIM
99
Sonora Investment Management
Arizona
$5K +$7.87K +500 New
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$3K +$4.14K +263 +198%
2 3
4
5 6

LAB Hedge Fund Activity: Q3 2015 in Review

109 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2015, worth a combined $252M — down 66% from $750M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 22 closed out — a net gain of 3 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $20.6M. The largest seller was Jennison Associates, cutting an estimated $27.6M.

  • 109 institutional investors held Standard BioTools (LAB) as of Q3 2015, up from 107 in Q2 2015.
  • Funds reported $252M of Standard BioTools stock for Q3 2015, down 66% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q3 2015 and 22 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q3 2015 was Scopia Capital Management, an estimated $20.6M added.
  • The largest Standard BioTools seller in Q3 2015 was Jennison Associates, an estimated $27.6M sold.

Based on aggregated 13F filings for Q3 2015.